Fennec Pharmaceuticals Inc (NASDAQ:FENC)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - FENC
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - FENC
- Market Cap$188.510m
- SymbolNASDAQ:FENC
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINCA31447P1009
Company Profile
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
Latest FENC news
Currently there for this company. Visit our news hub for other news .